相关实验视频
Updated: Jun 7, 2025
10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
9.8K
一致和不一致的骨髓参与对扩散的大B细胞淋巴瘤的预后影响
Huaqin Zuo1, Xiaoyan Xie1, Xing Sun2
1Department of Hematology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, China.
Translational cancer research
|November 11, 2024
概括
在扩散性大B细胞淋巴瘤 (DLBCL) 中,一致性骨髓参与表明预后比不一致性参与更差. 通过排除不一致的骨髓参与来调整国际预后指数 (IPI),改善了DLBCL患者的生存预测.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床病理学 临床病理学
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 是一种异质的血液性恶性瘤.
- 骨髓 (BM) 在DLBCL中的参与呈现为一致或不一致.
- 以前的研究表明,与一致的BM参与相关的预后较差,需要进一步调查.
研究的目的:
- 分析一致与不一致的骨髓参与DLBCL的预后影响.
- 为了评估修改的国际预后指数 (IPI) 的实用性,该指数不包括不一致的BM参与,用于生存预测.
主要方法:
- 对32名新诊断的DLBCL患者的回顾性分析.
- 卡普兰-梅尔分析和日志等级测试的总生存 (OS) 和无进展生存 (PFS).
- 多变量考克斯回归分析以确定独立的预后因素并评估经BM调整的IPI.
主要成果:
- 与不一致的参与 (17 个患者) 相比,一致的BM参与 (15 个患者) 与年龄较大和乳酸脱酶升高有关.
- 具有一致的BM参与的患者表现出明显更差的OS (P=0.04) 和PFS (P=0.03).
- 经BM调整的IPI,不包括不一致的BM参与,与标准IPI (P=0.16) 相比,证明了改善的OS预测 (P=0.053),并且是OS的独立预测因子 (HR=3.406,P=0.03).
结论:
- 准确识别DLBCL中的BM透类型对于预后至关重要.
- 一致的BM参与是DLBCL的显著不良预后因素.
- 除了不一致的BM参与来调整IPI得分,可以提高其对DLBCL总体存活的预测准确性.
相关概念视频
01:22Bone Marrow Sampling and Transplants
286
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
286
01:27Disorders of Leukocytes
865
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
865